ADMA Biologics, Inc. (ADMA)
9.26
-0.13
(-1.38%)
USD |
NASDAQ |
Sep 11, 15:41
ADMA Biologics Gross Profit (TTM) : 331.27M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 331.27M |
| March 31, 2026 | 312.24M |
| December 31, 2025 | 292.62M |
| September 30, 2025 | 267.16M |
| June 30, 2025 | 251.21M |
| March 31, 2025 | 241.32M |
| December 31, 2024 | 219.16M |
| September 30, 2024 | 186.76M |
| June 30, 2024 | 151.60M |
| March 31, 2024 | 110.80M |
| December 31, 2023 | 88.22M |
| September 30, 2023 | 71.32M |
| June 30, 2023 | 56.32M |
| March 31, 2023 | 47.40M |
| December 31, 2022 | 34.55M |
| September 30, 2022 | 23.88M |
| June 30, 2022 | 14.61M |
| March 31, 2022 | 5.842M |
| December 31, 2021 | 0.4579M |
| September 30, 2021 | -9.781M |
| June 30, 2021 | -11.75M |
| March 31, 2021 | -16.45M |
| December 31, 2020 | -21.36M |
| September 30, 2020 | -14.78M |
| June 30, 2020 | -13.93M |
| Date | Value |
|---|---|
| March 31, 2020 | -12.18M |
| December 31, 2019 | -11.46M |
| September 30, 2019 | -18.43M |
| June 30, 2019 | -22.67M |
| March 31, 2019 | -25.47M |
| December 31, 2018 | -29.63M |
| September 30, 2018 | -24.98M |
| June 30, 2018 | -28.25M |
| March 31, 2018 | -23.92M |
| December 31, 2017 | -14.14M |
| September 30, 2017 | -11.57M |
| June 30, 2017 | -3.432M |
| March 31, 2017 | 0.1029M |
| December 31, 2016 | 0.1469M |
| September 30, 2016 | 1.234M |
| June 30, 2016 | 2.254M |
| March 31, 2016 | 0.7529M |
| December 31, 2015 | 0.7212M |
| September 30, 2015 | -0.9655M |
| June 30, 2015 | -2.225M |
| March 31, 2015 | -1.913M |
| December 31, 2014 | -1.678M |
| September 30, 2014 | -1.564M |
| June 30, 2014 | -0.6626M |
| March 31, 2014 | -0.1438M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Erasca, Inc. | -2.937M |
| Vericel Corp. | 228.38M |
| Emergent BioSolutions, Inc. | 363.30M |
| Exelixis, Inc. | 2.350B |
| Krystal Biotech, Inc. | 411.03M |